Objectives: Postpartum depression (PPD) is a major depressive disorder. Vitamin D deficiency may play a role in PPD pathogenesis. This study was designed to determine the effect of vitamin D and calcium supplementation on the severity of symptoms and some related inflammatory biomarkers in women with PPD. Materials and Methods: Eighty-one women with a PPD score >12 participated in this study. A total of 27 patients were randomly assigned into three groups (1:1:1 ratio) to receive either 50,000 IU vitamin D3 fortnightly + 500 mg calcium carbonate daily; or 50,000 IU vitamin D3 fortnightly + placebo of calcium carbonate daily, or placebo of vitamin D3 fortnightly + placebo of calcium carbonate daily (placebo group) for 8 weeks. At the baseline and end of the study, the severity score of PPD, levels of 25-hydroxy vitamin D, calcium, tumor necrosis factor-alpha (TNFα), interleukin 6 (IL6) and estradiol were measured. Results: The PPD score had more reduction in the vitamin D + calcium and vitamin D + calcium placebo groups than that of the placebo group (−1.7 ± 3.44, −4.16 ± 5.90 and 0.25 ± 2.81, respectively; p = 0.008). The effect of vitamin D on the PPD score was larger when vitamin D was given alone than given together with calcium (p = 0.042 and p = 0.004, respectively). No significant differences in estradiol, IL6 and TNFα were observed between the three groups. Discussion: Vitamin D may be effective in improving the clinical symptoms of PPD; however, the mechanism of the effect might not entirely operate through inflammatory and/or hormonal changes.
Background: Persistent fatigue is a common symptom of methamphetamine withdrawal. It disrupts the individual’s social and professional lives as well as increasing the risk of relapse. This study aimed to assess the effects of amantadine in the treatment of persistent fatigue in methamphetamine-abstained individuals.Methods: A double-blind, placebo-controlled trial was conducted on 42 methamphetamine-abstained individuals who sought treatment for persistent fatigue. Participants were randomly assigned to two groups, receiving either amantadine 100 mg/day or placebo for 4 weeks. Treatment response was evaluated using Fatigue Severity Scale (FSS) and Chalder Fatigue Scale (CFS), recorded at the beginning and end of trial.Results: A substantial reduction in both fatigue scales was found in the amantadine group, while there was no significant change in the placebo group. Fatigue reduction in the amantadine and placebo groups was, respectively, 28% versus 6% (p < 0.001) using the FSS and 24.3% and 4.5% (p < 0.001) using the CFS. In addition, both scales showed that the rate of fatigue recovery was significantly higher in the amantadine versus placebo group (p < 0.05).Conclusions: Persistent fatigue in methamphetamine-abstained individuals was significantly reduced, and higher rate of fatigue recovery achieved, from daily administration of 100 mg amantadine for 4 weeks.
Objective. Obsessive compulsive disorder (OCD) is a chronic disorder of unknown etiology. An augmentation strategy is an approach for treatment-resistant OCD. This study was planned to assess the effect of atorvastatin on treatment-resistant OCD. Methods. This 12-week-long double-blind randomized trial was performed on 26 adult patients with treatment-resistant OCD. They were diagnosed with this kind of disorder based on the DSM-IV-TR. The patients were randomized to receive either 10 mg/day atorvastatin or placebo. The Yale-Brown scale was assessed at the baseline and 12 weeks later. Results. There were significant reductions in the obsession subtotal score of the Y-BOCS (p = 0.017) and the total Y-BOCS score (p = 0.041) in the atorvastatin group. Hence, the reduction in the Y-BOCS compulsive score (p = 0.081) was not statistically significant. Atorvastatin was generally well tolerated. There was a significant reduction in libido in the atorvastatin group (p = 0.019). Conclusions. The results of this study should be interpreted in the shadow of its restrictions. Some of the restrictions were a limited number of patients in the trial, a 12-week-long time trial, and not measuring NO before and after the study. It is recommended that researchers should consider these items in similar type of studies.
1 December 2023 in Central Nervous System Agents in Medicinal Chemistry
Introduction: Mental disorders during pregnancy are one of the major public health problems because of its effect on both mother and child, but the prevalence of psychiatric disorders in infertile women is largely unknown to compare psychiatric disorders during and after pregnancies with assisted reproductive therapies (ART) and spontaneous pregnancies. Methods: This cross-sectional study was conducted on pregnant women referring to midwifery centers in Ahvaz City in 2022. Pregnant women were included in two groups of either pregnancy caused by ART (n= 84) or spontaneous pregnancy (n= 256). The Symptom Checklist-90-R (SCL- 90-R) was used to assess psychiatric disorders during and after pregnancies. Results: A high percentage of women with spontaneous pregnancy (74.6%) and ART (91.7%) had some degree of psychological disorders. The severity of psychological disorders in both groups was higher during pregnancy than after pregnancy (p<0.001). The intensity of various psychological disorders during and after pregnancy in the ART pregnancy group was significantly higher than the control group (p<0.001). An increased risk of psychiatric disorders during pregnancy was associated with the history of psychiatric disorders [odd ratio (OR): 12.393; P= 0.022], family history of psychiatric disorders (OR:26.168; p<0.001), history of infertility (OR: 19.00; p<0.001), primary infertility (OR: 12.714; P=0.004), infertility duration more than three years (OR: 43.424; p<0.001), and frequency of embryo transfer (OR: 18.939; P=0.045). Conclusion: Psychiatric disorders were prevalent among pregnant women in the study area especially in pregnant women with ART. Regular screening programs for mental health problem should be included in an antenatal care service especially in this high-risk group.
25 March 2013 in Expert Opinion on Drug Metabolism & Toxicology
Introduction: Obsessive–compulsive disorder (OCD) affects the daily life of the patients. Chronic nature of this disease and the need for long-term high-dose drug therapy for its maintenance increase the risk of metabolic and toxicological complications. Areas covered: In this concise article, the metabolic and toxicological aspects of major medication categories prescribed in OCD, such as serotonin-specific reuptake inhibitors, tricyclic antidepressant (clomipramine), serotonin-norepinephrine reuptake inhibitors, and atypical antipsychotics indicated in OCD (both Food and Drug Administration-approved and off-label) are discussed. Expert opinion: The most critical point in pharmacotherapy of OCD is the need for the high-dose and long-term use of drugs. In OCD, generally the higher doses of applicable drugs than those used in depression are required, often exceeding the recommended maximum dose. Moreover, such high doses should be given for at least 10 – 12 weeks to ensure the adequate treatment duration for the clinical effects to emerge. This long-term high-dose maintenance therapy increases the risk of drug toxicity and adverse effects. Physicians should take extra care in periodical assessment of signs and symptoms of metabolic and toxicological complications in patients. Subjective symptoms reported by patients should be carefully assessed and not attributed to obsessive nature of the patients.
25 November 2020 in Hospital Practices and Research
Background: Poor teaching and lack of proper relations between teacher and student and various other causes affect students’ academic burnout. Objectives: Present study was conducted to determine the relationship between educational justice and academic burnout in medical interns of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Methods: This study was descriptive and analytical. The number of samples was equal to 300 medical interns identified and entered by the census sampling method. Data were completed by two questionnaires (researcher-made educational justice and burnout standard) whose reliability and validity were confirmed. Data were analyzed by SPSS Version 22. Results: There was no significant relationship between educational justice and academic burnout (P>0.05). Also, educational justice was below average and academic burnout was above average. There was a significant relationship between educational justice score and gender (P0.05). There was no significant relationship between academic burnout score and all demographic variables (P>0.05). Conclusion: This study concluded that causes other than educational justice have been influential on students’ academic burnout. Hence, it suggested that studies be conducted on high academic burnout and identify influential variables. On the other hand, although the relationship between the two variables was not significant, due to the low level of educational justice, the university’s need for fair educational opportunities, especially professors, should be considered.